Mary T. Hawn

2 months ago | jamanetwork.com | Anjali Dixit |Brian Bateman |Mary T. Hawn |Michelle C. Odden

Preoperative SGLT2 Inhibitor Use and Postoperative Diabetic Ketoacidosis Key PointsQuestion  Is preoperative use of sodium-glucose cotransporter 2 inhibitor (SGLT2i) medication associated with postoperative occurrence of diabetic ketoacidosis?

Jun 1, 2024 | jamanetwork.com | Anjali Dixit |Brian Bateman |Mary T. Hawn |Marc Levi

Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications GLP-1 Receptor Agonist Use and Risk of Postoperative Complications Anjali A. Dixit, MD, MPH; Brian T. Bateman, MD, MS; Mary T. Hawn, MD, MPH; Michelle C. Odden, PhD; Eric C. Sun, MD, PhD Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications—Reply Anjali A. Dixit, MD, MPH; Brian T. Bateman, MD, MS; Eric C.

Jun 1, 2024 | jamanetwork.com | Anjali Dixit |Brian Bateman |Mary T. Hawn |Ion A. Hobai

Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications GLP-1 Receptor Agonist Use and Risk of Postoperative Complications Anjali A. Dixit, MD, MPH; Brian T. Bateman, MD, MS; Mary T. Hawn, MD, MPH; Michelle C. Odden, PhD; Eric C. Sun, MD, PhD Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications—Reply Anjali A. Dixit, MD, MPH; Brian T. Bateman, MD, MS; Eric C.

Jun 1, 2024 | jamanetwork.com | Brian Bateman |Eric Sun |Anjali Dixit |Mary T. Hawn

Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications—Reply GLP-1 Receptor Agonist Use and Risk of Postoperative Complications Anjali A. Dixit, MD, MPH; Brian T. Bateman, MD, MS; Mary T. Hawn, MD, MPH; Michelle C. Odden, PhD; Eric C. Sun, MD, PhD Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications David A. Milder, BMedMD, BSc; Tamara Y.

Apr 22, 2024 | jamanetwork.com | Anjali Dixit |Brian Bateman |Mary T. Hawn |Michelle C. Odden

Preoperative GLP-1 Receptor Agonist Use and Risk of Postoperative Respiratory Complications GLP-1 Agonists and Gastrointestinal Adverse Events Mohit Sodhi, MSc; Ramin Rezaeianzadeh, BSc; Abbas Kezouh, PhD; Mahyar Etminan, PharmD, MSc Glucagon-Like Peptide-1 Receptor Agonist Use and Risk of Gallbladder and Biliary Diseases Liyun He, MM; Jialu Wang, MM; Fan Ping, MD; Na Yang, MM; Jingyue Huang, MM; Yuxiu Li, MD; Lingling Xu, MD; Wei Li, MD; Huabing Zhang, MD Glucagon-Like Peptide-1 Receptor...